BARDA ACTIVE.....Maybe B is next. Inovio Pharmaceuticals (NASDAQ:INO): partnering with Ology Bioservices to manufacture INO-4800 (its DNA vaccine) for the prevention of COVID-19 infection. BARDA has provided $11.9M in funding to Ology to support the effort. Shares up 17% premarket.